Richard Harris
-
Scientists who study mushrooms get a boost from a network of sophisticated aficionados who tromp through the forests observing oddball species and sharing valuable information about their finds.
-
Though the odds are comparable, many parents worry more about the less familiar disease. New mask guidelines have heightened anxiety. Experts explain the actual versus perceived risks of severe COVID.
-
A mushroom thought extinct in the US for 100 years has been rediscovered. It's an example of the remarkable synergy between amateur and professional fungus aficionados.
-
Drugs that can help keep COVID-19 patients out of the hospital are playing only a small role in Michigan, where the pandemic is accelerating. Logistical challenges are to blame.
-
Government health officials are recommending a "pause" in vaccinations with the Johnson & Johnson COVID-19 vaccine. We're answering your questions as we learn more.
-
Researchers are reporting some progress in their search for drugs that tamp down the overwhelming immune reaction that can kill a patient with COVID-19.
-
A medical team in New York City says it has performed the first complete surgical transplant of a trachea. These kinds of transplants are one of the last big transplant challenges.
-
Many doctors have used antibiotics to treat COVID-19 patients, but that's largely unnecessary — and could even promote drug-resistant germs.
-
Infusing blood plasma from people who have recovered from COVID-19 into sick patients looks good on paper. But studies of the treatment haven't found benefits.
-
People who have been sick with COVID-19 may need only one dose of the normally two-shot vaccines. If that became policy it could extend vaccine supplies, but logistical challenges are daunting.